Where is the live CopyMark page for USPTO serial 85163805?

The live record is at https://getcopymark.com/trademark/85163805. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns MYCLAIMIQ GENIE?

According to the public USPTO record for serial number 85163805, the listed owner(s) include: HealthTech Solutions Group, LLC, HealthTech Solutions Group, LLC, HealthTech Solutions Group, LLC.

What is USPTO serial number 85163805?

Serial number 85163805 is the USPTO application identifier for the mark MYCLAIMIQ GENIE. It is used to track examination, publication, and registration of this trademark.

What is the current status of MYCLAIMIQ GENIE?

MYCLAIMIQ GENIE (85163805) currently shows USPTO status code 711 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Which trademark classes cover MYCLAIMIQ GENIE?

The public record lists International Classes: 009. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: MYCLAIMIQ GENIE Serial# 85163805 | status 711; last event C7.. | Trademark Info & Attorney Guidance

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MYCLAIMIQ GENIE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Robert L. Brewer, Paige W. Mills, and Ryann M. Schneider

ROBERT L. BREWER BASS, BERRY & SIMS PLC150 3RD AVE S STE 2800NASHVILLE, TN 37201-2017UNITED STATES

Goods and services

Class	Description	Status	First use
009	Downloadable software for revenue cycle management and analysis, billing and managing accounts receivable, all in the field of healthcare	SECTION 7(e) - CANCELLED	Sep 1, 2010

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Apr 29, 2014	C7..	CANCELLED SECTION 7-TOTAL	—
Apr 23, 2014	APRE	CASE ASSIGNED TO POST REGISTRATION PARALEGAL	—
Apr 18, 2014	C7RF	REQUEST FOR SECT 7 TOTAL SURRENDER FILED	—
Apr 18, 2014	ES7S	TEAS SECTION 7 SURRENDER RECEIVED	—
Aug 22, 2013	CHAN	APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED	—
Aug 22, 2013	COAR	TEAS CHANGE OF OWNER ADDRESS RECEIVED	—
Nov 22, 2011	R.PR	REGISTERED-PRINCIPAL REGISTER	Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 20, 2011	SUNA	NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED	—
Oct 19, 2011	REGV	LAW OFFICE REGISTRATION REVIEW COMPLETED	—
Oct 14, 2011	CNPR	ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED	—
Oct 7, 2011	SUPC	STATEMENT OF USE PROCESSING COMPLETE	—
Oct 6, 2011	AITU	CASE ASSIGNED TO INTENT TO USE PARALEGAL	—
Oct 4, 2011	IUAF	USE AMENDMENT FILED	—
Oct 4, 2011	EISU	TEAS STATEMENT OF USE RECEIVED	The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jun 14, 2011	NOAM	NOA E-MAILED - SOU REQUIRED FROM APPLICANT	A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 19, 2011	NPUB	OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	—
Apr 19, 2011	PUBO	PUBLISHED FOR OPPOSITION	Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 11, 2011	PREV	LAW OFFICE PUBLICATION REVIEW COMPLETED	—
Mar 11, 2011	ALIE	ASSIGNED TO LIE	—
Feb 16, 2011	CNSA	APPROVED FOR PUB - PRINCIPAL REGISTER	—
Feb 16, 2011	XAEC	EXAMINER'S AMENDMENT ENTERED	—
Feb 16, 2011	GNEN	NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED	—
Feb 16, 2011	GNEA	EXAMINERS AMENDMENT E-MAILED	—
Feb 16, 2011	CNEA	EXAMINERS AMENDMENT -WRITTEN	—
Feb 10, 2011	GNRN	NOTIFICATION OF NON-FINAL ACTION E-MAILED	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 10, 2011	GNRT	NON-FINAL ACTION E-MAILED	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 10, 2011	CNRT	NON-FINAL ACTION WRITTEN	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 7, 2011	DOCK	ASSIGNED TO EXAMINER	—
Nov 3, 2010	MPMK	NOTICE OF PSEUDO MARK MAILED	—
Nov 2, 2010	NWOS	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED	—

MYCLAIMIQ GENIE